1.Pretreatment neutrophil-to-lymphocyte ratio is a predictive biomarker for EGFR TKI-treated patients with advanced EGFR-mutant Non-small cell lung cancer
Xu, C, Yao, XJ, Li,
More...
Xu, C, Yao, XJ, Li, T, Wang, J, An, B, Wang, J, Sui, XB, Leung, ELH, Wu, QB
Less
TRANSLATIONAL CANCER RESEARCH[2218-676X],
Published 2020,
Volume 9,
Issue 4,
Pages 2875-2883
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 6
2023影響因子:
1.5
发表年影響因子:
1.241